Search for
Results of search for pharmaceutical
Records found: 20
| DP15544 |
Licensing Life-Saving Drugs for Developing Countries: Evidence from the Medicines Patent Pool Author(s): Alberto Galasso and Mark Schankerman Published: December 2020 |
| DP15433 |
Optimal Subsidies for Prevention of Infectious Disease Author(s): Matthew Goodkin-Gold, Michael Kremer, Christopher Snyder and Heidi Williams Published: November 2020 |
| DP15279 |
Pricing above value: selling to an adverse selection market Author(s): Jan Boone Published: September 2020 |
| DP14035 |
Market Definition and Competition Policy Enforcement in the Pharmaceutical Industry Author(s): Micael Castanheira, Carmine Ornaghi and Georges Siotis Published: October 2019 |
| DP14019 |
Dominance and the pre-emption of competition following the Servier and Paroxetine GSK judgments Author(s): Vilen Lipatov, Damien J Neven and Georges Siotis Published: September 2019 |
| DP12751 |
Preventives Versus Treatments Redux: Tighter Bounds on Distortions in Innovation Incentives with an Application to the Global Demand for HIV Pharmaceuticals Author(s): Michael Kremer and Christopher Snyder Published: February 2018 |
| DP12649 |
On the Effect of Parallel Trade on Manufacturers' and Retailers' Profits in the Pharmaceutical Sector Author(s): Pierre Dubois and Morten Saethre Published: January 2018 |
| DP12419 |
Strategic Interaction Among Governments in the Provision of a Global Public Good Author(s): Margaret K Kyle, David Ridley and Su Zhang Published: November 2017 |
| DP11813 |
The Unexpected Consequences of Asymmetric Competition. An Application to Big Pharma Author(s): Micael Castanheira, Maria-Angeles de Frutos, Carmine Ornaghi and Georges Siotis Published: January 2017 |
| DP11487 |
The Effects of Pharmaceutical Innovation on Cancer Mortality Author(s): Pierre Dubois and Margaret K Kyle Published: September 2016 |
| DP10474 |
Vaccines vs. Preventives Author(s): Michael Kremer and Christopher Snyder Published: March 2015 |
| DP9881 |
Identifying Industry Margins with Unobserved Price Constraints: Structural Estimation on Pharmaceuticals Author(s): Pierre Dubois and Laura Lasio Published: March 2014 |
| DP9420 |
Does the market choose optimal health insurance coverage? Author(s): Jan Boone Published: April 2013 |
| DP9140 |
Impacts of Patent Expiry and Regulatory Policies on Daily Cost of Pharmaceutical Treatments: OECD Countries, 2004-2010 Author(s): Ernst R Berndt and Pierre Dubois Published: September 2012 |
| DP8481 |
Does Europe have an innovation policy? The case of EU economic law Author(s): Lauren Battaglia, Pierre Larouche and Matteo Negrinotti Published: July 2011 |
| DP8371 |
Investments in Pharmaceuticals Before and After TRIPS Author(s): Margaret K Kyle and Anita M McGahan Published: May 2011 |
| DP8367 |
Market Size and Pharmaceutical Innovation Author(s): Oliver de Mouzon, Pierre Dubois, Fiona Scott Morton and Paul Seabright Published: April 2011 |
| DP8076 |
Competition in the Pharmaceutical Industry: How do Quality Differences Shape Advertising Strategies? Author(s): Maria-Angeles de Frutos, Carmine Ornaghi and Georges Siotis Published: October 2010 |
| DP5779 |
Parallel Imports and Price Controls Author(s): Gene M. Grossman and Edwin Lai Published: August 2006 |
| DP675 |
Pharmaceuticals - Who's Afraid of `1992'? Author(s): Gernot Klepper Published: March 1992 |
Records Found 20